Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201303150 Principal Investigator: Tan, Benjamin
Title: A phase I/II study of X-82, an oral anti-VEGFR tyrosine kinase inhibitor, with everolimus for patients with pancreatic neuroendocrine tumors
Phase: I/II Disease Site: Pancreas
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to determine the best dose of a drug called X-82 when it is combined with everolimus, as well as to look at side effects that may occur when people receive this combination of drugs.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)